Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-23-000113 General Corporate
Debt relative to revenue 0th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.debt_to_revenue
70.14% · OPTIONAL · VALID
Capex intensity 21th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.01% · OPTIONAL · VALID
Operating cash generation 68th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.59% · OPTIONAL · VALID
Revenue growth 29th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
48.22% · CORE · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.56% · CORE · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-14.51% · CORE · VALID
R&D intensity 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.63% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
27.51% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 272.41%
Current 70.14%
Delta -202.27% Capex Intensity Decreased
Previous 6.27%
Current 6.01%
Delta -0.26% Cash Generation Increased
Previous 25.90%
Current 28.59%
Delta 2.69% Growth Increased
Previous 46.02%
Current 48.22%
Delta 2.19% Margin Increased
Previous 77.11%
Current 77.56%
Delta 0.45% Profitability Decreased
Previous -13.31%
Current -14.51%
Delta -1.20% R And D Intensity Decreased
Previous 22.12%
Current 21.63%
Delta -0.49% Sbc Intensity Increased
Previous 25.74%
Current 27.51%
Delta 1.77% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.